MedTrace Logo

Treatment Outcomes Among Patients With Prescription Narcotic Drug Use Disorder

NCT03713983 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2025-09-16

No results posted yet for this study

Summary

This study follows up patients who receive standard treatment for prescription narcotic drug use disorder, including opioids, benzodiazepines, and benzodiazepine-like drugs (z-drugs), at a specialized addiction service. The overall goal is to evaluate the proportion of patients who reduce or cease using prescription narcotics and the factors associated with treatment outcomes. No new treatments will be tested. Instead, the results will be used as the basis for a future randomized controlled trial to optimize treatment for narcotic drug use disorder.

Conditions

  • Drug Use Disorders

Interventions

OTHER

Observational study

Observational study

Sponsors & Collaborators

  • Public Health Agency of Sweden

    collaborator OTHER_GOV

  • Johan Franck

    lead OTHER

Principal Investigators

  • Johan Franck, Professor · Karolinska Institutet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-23
Primary Completion
2029-12-31
Completion
2029-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03713983 on ClinicalTrials.gov